Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Rhythm Pharmaceuticals, Inc. RYTM

Set alert

Price alert · RYTM

All alert types
84.15 USD -9.29 -9.94%

As of Nov 3, 10:36 AM ET

Bid
84.02 × 1
Ask
84.25 × 1
82.05 Day range 88.26
75.82 52-week range 117.62
YTD
-21.38%
1 year
-26.02%
Open
86.54
Prev close
93.44
Mkt cap
5.76B
Vol
2.47M
Avg vol
675.20K
EPS
-3.12
P/E
0.00
Div yield
0.00%
More statistics
Low
82.05
High
88.26
Forward P/E
-148.67
Beta
2.13
Short ratio
13.64
Inst. own
115.08%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
97.18
200-d avg
97.09
1y target
140.53

1M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Oct 8, 2026Rating: RBC Capital · Outperform → Outperform
  • Oct 12, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Oct 15, 2026Rating: JP Morgan · Overweight → Overweight
  • Oct 16, 2026Rating: William Blair · — → Outperform
  • Nov 3, 2026Earnings: —; estimate -0.70968; surprise —%
Signals (5)
NameDateAgo
SMA: BearishNov 3, 20261 hour ago
SMA: BullishOct 20, 20262 weeks ago
MACD: Buy SignalOct 20, 20262 weeks ago
RSI: OversoldOct 16, 20262 weeks ago
RSI: OversoldOct 13, 20263 weeks ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 140.53 +67.0% upside
Target (low)
120.00
Target (mean)
140.53
Target (high)
160.00
Ratings (0m) 19 17 buy · 2 hold · 0 sell
  • Strong buy5
  • Buy12
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 19
  • 1 month ago 18
  • 2 months ago 17

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

RYTM analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.74252-0.85 – -0.66-0.82+9.4%84.60M+64.9%13
Next quarter-0.72859-0.93 – -0.57-0.73+0.2%99.17M+73.2%13
Current year-3.04-3.36 – -2.82-3.11+2.1%315.27M+66.1%13
Next year-0.6285-2.45 – 0.49-3.04+79.3%565.12M+79.3%13

Upgrades and downgrades

The latest rating changes

RYTM analyst upgrades and downgrades
DateFirmActionFromTo
Oct 16, 2026William BlairInitiated—Outperform
Oct 15, 2026JP MorganMaintainedOverweightOverweight
Oct 12, 2026HC Wainwright & Co.MaintainedBuyBuy
Oct 8, 2026RBC CapitalMaintainedOutperformOutperform
Aug 28, 2026Deutsche BankInitiated—Hold
Aug 7, 2026JP MorganMaintainedOverweightOverweight
Aug 5, 2026CitigroupMaintainedBuyBuy
Aug 5, 2026RBC CapitalMaintainedOutperformOutperform
Aug 5, 2026CitizensMaintainedMarket OutperformMarket Outperform
Jul 27, 2026JP MorganInitiated—Overweight
Jul 7, 2026RBC CapitalMaintainedOutperformOutperform
Jun 16, 2026Canaccord GenuityMaintainedBuyBuy
Jun 15, 2026Wells FargoMaintainedOverweightOverweight
May 7, 2026Canaccord GenuityMaintainedBuyBuy
May 6, 2026RBC CapitalMaintainedOutperformOutperform
May 6, 2026Wells FargoMaintainedOverweightOverweight
Mar 23, 2026HC Wainwright & Co.MaintainedBuyBuy
Mar 20, 2026CitigroupMaintainedBuyBuy
Mar 20, 2026B of A SecuritiesMaintainedBuyBuy
Mar 20, 2026CitizensMaintainedMarket OutperformMarket Outperform
Mar 18, 2026HC Wainwright & Co.MaintainedBuyBuy
Mar 17, 2026CitigroupMaintainedBuyBuy
Mar 17, 2026RBC CapitalMaintainedOutperformOutperform
Mar 17, 2026CitizensMaintainedMarket OutperformMarket Outperform
Mar 17, 2026B of A SecuritiesMaintainedBuyBuy
Mar 17, 2026Morgan StanleyMaintainedOverweightOverweight
Mar 17, 2026NeedhamMaintainedBuyBuy
Mar 12, 2026Wells FargoMaintainedOverweightOverweight
Mar 2, 2026Canaccord GenuityMaintainedBuyBuy
Mar 2, 2026HC Wainwright & Co.MaintainedBuyBuy